These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 28634644)
1. Minimal Clinically Important Differences (MCID) in Assessing Outcomes of Post-Traumatic Stress Disorder. Stefanovics EA; Rosenheck RA; Jones KM; Huang G; Krystal JH Psychiatr Q; 2018 Mar; 89(1):141-155. PubMed ID: 28634644 [TBL] [Abstract][Full Text] [Related]
2. Correlates of Nonimprovement to Pharmacotherapy for Chronic, Antidepressant-Resistant, Military Service-Related Posttraumatic Stress Disorder: Insights From the Veterans Affairs Cooperative Study No. 504. Byrne SP; Krystal JH; Rosenheck RA; Vessicchio J; Pietrzak RH; J Clin Psychopharmacol; 2017 Dec; 37(6):717-721. PubMed ID: 28945664 [TBL] [Abstract][Full Text] [Related]
3. Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial. Krystal JH; Rosenheck RA; Cramer JA; Vessicchio JC; Jones KM; Vertrees JE; Horney RA; Huang GD; Stock C; JAMA; 2011 Aug; 306(5):493-502. PubMed ID: 21813427 [TBL] [Abstract][Full Text] [Related]
4. Trial of Prazosin for Post-Traumatic Stress Disorder in Military Veterans. Raskind MA; Peskind ER; Chow B; Harris C; Davis-Karim A; Holmes HA; Hart KL; McFall M; Mellman TA; Reist C; Romesser J; Rosenheck R; Shih MC; Stein MB; Swift R; Gleason T; Lu Y; Huang GD N Engl J Med; 2018 Feb; 378(6):507-517. PubMed ID: 29414272 [TBL] [Abstract][Full Text] [Related]
5. Characterizing the Effects of Quetiapine in Military Post-Traumatic Stress Disorder. Villarreal G; Hamner MB; Qualls C; Cañive JM Psychopharmacol Bull; 2018 Feb; 48(2):8-17. PubMed ID: 29713096 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of Quetiapine Monotherapy in Posttraumatic Stress Disorder: A Randomized, Placebo-Controlled Trial. Villarreal G; Hamner MB; Cañive JM; Robert S; Calais LA; Durklaski V; Zhai Y; Qualls C Am J Psychiatry; 2016 Dec; 173(12):1205-1212. PubMed ID: 27418378 [TBL] [Abstract][Full Text] [Related]
7. An open-label assessment of aripiprazole in the treatment of PTSD. Robert S; Hamner MB; Durkalski VL; Brown MW; Ulmer HG Psychopharmacol Bull; 2009; 42(1):69-80. PubMed ID: 19204652 [TBL] [Abstract][Full Text] [Related]
8. Quetiapine treatment in an open trial in combat-related post-traumatic stress disorder with psychotic features. Kozaric-Kovacic D; Pivac N Int J Neuropsychopharmacol; 2007 Apr; 10(2):253-61. PubMed ID: 16945162 [TBL] [Abstract][Full Text] [Related]
9. Prospective study to evaluate the efficacy of aripiprazole as a monotherapy in patients with severe chronic posttraumatic stress disorder: an open trial. Villarreal G; Calais LA; Cañive JM; Lundy SL; Pickard J; Toney G Psychopharmacol Bull; 2007; 40(2):6-18. PubMed ID: 17514183 [TBL] [Abstract][Full Text] [Related]
10. Concordance in PTSD symptom change between DSM-5 versions of the Clinician-Administered PTSD Scale (CAPS-5) and PTSD Checklist (PCL-5). Lee DJ; Weathers FW; Thompson-Hollands J; Sloan DM; Marx BP Psychol Assess; 2022 Jun; 34(6):604-609. PubMed ID: 35389681 [TBL] [Abstract][Full Text] [Related]
11. Applying the PTSD Checklist-Civilian and PTSD Checklist for DSM-5 crosswalk in a traumatic brain injury sample: A veterans affairs traumatic brain injury model systems study. Wyant HN; Silva MA; Agtarap S; Klocksieben FA; Smith T; Nakase-Richardson R; Miles SR Psychol Assess; 2024; 36(6-7):425-432. PubMed ID: 38829350 [TBL] [Abstract][Full Text] [Related]
12. An open-label pilot study of aripiprazole for male and female veterans with chronic post-traumatic stress disorder who respond suboptimally to antidepressants. Youssef NA; Marx CE; Bradford DW; Zinn S; Hertzberg MA; Kilts JD; Naylor JC; Butterfield MI; Strauss JL Int Clin Psychopharmacol; 2012 Jul; 27(4):191-6. PubMed ID: 22475888 [TBL] [Abstract][Full Text] [Related]
14. Effect of Stellate Ganglion Block Treatment on Posttraumatic Stress Disorder Symptoms: A Randomized Clinical Trial. Rae Olmsted KL; Bartoszek M; Mulvaney S; McLean B; Turabi A; Young R; Kim E; Vandermaas-Peeler R; Morgan JK; Constantinescu O; Kane S; Nguyen C; Hirsch S; Munoz B; Wallace D; Croxford J; Lynch JH; White R; Walters BB JAMA Psychiatry; 2020 Feb; 77(2):130-138. PubMed ID: 31693083 [TBL] [Abstract][Full Text] [Related]
15. A comparison of the CAPS-5 and PCL-5 to assess PTSD in military and veteran treatment-seeking samples. Resick PA; Straud CL; Wachen JS; LoSavio ST; Peterson AL; McGeary DD; Young-McCaughan S; Taylor DJ; Mintz J; Eur J Psychotraumatol; 2023; 14(2):2222608. PubMed ID: 37350229 [TBL] [Abstract][Full Text] [Related]
16. A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military Veterans resistant to antidepressant treatment. Naylor JC; Kilts JD; Bradford DW; Strauss JL; Capehart BP; Szabo ST; Smith KD; Dunn CE; Conner KM; Davidson JR; Wagner HR; Hamer RM; Marx CE Int Clin Psychopharmacol; 2015 May; 30(3):167-74. PubMed ID: 25647451 [TBL] [Abstract][Full Text] [Related]
17. Change in posttraumatic stress disorder symptoms: do clinicians and patients agree? Monson CM; Gradus JL; Young-Xu Y; Schnurr PP; Price JL; Schumm JA Psychol Assess; 2008 Jun; 20(2):131-8. PubMed ID: 18557690 [TBL] [Abstract][Full Text] [Related]
18. Sleep disturbance in chronic military-related PTSD: clinical impact and response to adjunctive risperidone in the Veterans Affairs cooperative study #504. Krystal JH; Pietrzak RH; Rosenheck RA; Cramer JA; Vessicchio J; Jones KM; Huang GD; Vertrees JE; Collins J; Krystal AD; J Clin Psychiatry; 2016 Apr; 77(4):483-91. PubMed ID: 26890894 [TBL] [Abstract][Full Text] [Related]
19. Assessing posttraumatic stress disorder with close others' collateral reports: Convergence with self- and clinician reports. Ennis N; Sijercic I; Wanklyn SG; Monson CM J Fam Psychol; 2021 Mar; 35(2):258-263. PubMed ID: 33119366 [TBL] [Abstract][Full Text] [Related]
20. Adaptive behavior in autism: Minimal clinically important differences on the Vineland-II. Chatham CH; Taylor KI; Charman T; Liogier D'ardhuy X; Eule E; Fedele A; Hardan AY; Loth E; Murtagh L; Del Valle Rubido M; San Jose Caceres A; Sevigny J; Sikich L; Snyder L; Tillmann JE; Ventola PE; Walton-Bowen KL; Wang PP; Willgoss T; Bolognani F Autism Res; 2018 Feb; 11(2):270-283. PubMed ID: 28941213 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]